Skip to main content
HEALTH SOLUTIONS

Analytics

Overview

Improving processes, creating solutions

INSIGHT

Milliman analytics insight

White Paper

Role of data in transforming UK private medical insurance analytics

Data quality and integrity are of more importance now than atany other time in history. Insurers and providersare delving into advanced analytics, hopingto achieve more precise decisions for a range of applications.

Case Study

Using the Milliman Advanced Risk Adjusters (MARA) tool in the UK PMI market

Fuel population health analytics and manage risk adjustment with our award-winning suite of tools and data.

Article

Genomic testing: Cost-savings or cost-inflating for payers

The rapid uptake of genetic testing within the National Health Service (NHS) and current debate around genetics make evaluating tailored interventions increasingly more relevant to ensure an efficient use of NHS spend.
Presentation

Care management impact model

This model helps quantify the impact of care management programmes and redirecting care within the system on overall healthcare resource utilisation. Our tailored approach allows a range of different managed care programmes to be modelled.

Presentation

Actuarial cost projection model

Using our proprietary Health Cost Guidelines grouper, Milliman’s population cost model (PCM) helps you standardise measures of cost and utilisation across services and populations.

Presentation

International best practice benchmarks

Milliman’s International Best Practice Benchmarks help quantify potentially avoidable admissions and beddays within a healthcare system to identify potential value opportunities.

Case study

A case study: Risk adjustment in the UK PMI market

Developing a robust population stratification methodology in the UK private insurance market (PMI) environment has some challenges. There is limited primary care coverage for chronic conditions or emergency and maternity coverage.
Case Study

Population health and value-based care collaboration: Primary care case study

This paper discusses the primary care redesign of seven US practices over the course of three years, including their reported utilisation and savings achievements.

White Paper

Genetic testing in England: ROI, cost-effectiveness analysis, or both to evaluate intervention

The rapid uptake of genetic testing within the National Health Service (NHS) and current debate around genetics make evaluating tailored interventions increasingly more relevant to ensure an efficient use of NHS spend.

White Paper

Looking at cancer trends through Milliman UK Health Cost Guidelines

This article provides an introduction to the Milliman’s UK Health Cost Guidelines™ (HCGs), and insight into our findings, focusing primarily on the cancer-related research and future projections in cancer trends.

Milliman Inpatient Benchmarking Tool

Learn moreNavigation Arrow

Value of care categories (VCCs)

Related products

Milliman analytics products

Healthcare cost modelling

Health Cost Guidelines Suite

Learn moreNavigation Arrow
Healthcare risk adjustment

Milliman Advanced Risk Adjusters

Learn moreNavigation Arrow
IBNP reserve estimation

Claim Reserve Estimation Workbook (CREW)

Learn moreNavigation Arrow
Financial Modeling Platform with Excel language

Milliman MIND

Learn moreNavigation Arrow
Healthcare analytics

MedInsight

Learn moreNavigation Arrow
Medical underwriting

Milliman Medical Underwriting Suite

Learn moreNavigation Arrow
Related services

Milliman analytics services

Resources

Milliman analytics resources

Presentation

Actuarial cost projection model

Using our proprietary Health Cost Guidelines grouper, Milliman’s population cost model (PCM) helps you standardise measures of cost and utilisation across services and populations.

Presentation

International best practice benchmarks

Milliman’s International Best Practice Benchmarks help quantify potentially avoidable admissions and beddays within a healthcare system to identify potential value opportunities.

Case study

A case study: Risk adjustment in the UK PMI market

Developing a robust population stratification methodology in the UK private insurance market (PMI) environment has some challenges. There is limited primary care coverage for chronic conditions or emergency and maternity coverage.
Article

Genomic testing: Cost-savings or cost-inflating for payers

The rapid uptake of genetic testing within the National Health Service (NHS) and current debate around genetics make evaluating tailored interventions increasingly more relevant to ensure an efficient use of NHS spend.

We’re here to help